专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08969373B2 HCV protease inhibitors 有权
标题翻译： HCV蛋白酶抑制剂
公开(公告)号：US08969373B2
公开(公告)日：2015-03-03
申请号：US14236468
申请日：2012-07-23
申请人： Suoming Zhang
发明人： Suoming Zhang
IPC分类号： C07D491/048 , C07D495/04 , C07D207/16 , A61K31/4355 , A61K31/4365 , A61K31/437 , C07K5/08 , C07K5/083
CPC分类号： C07D495/04 , C07D207/16 , C07D491/048 , C07K5/06165 , C07K5/0802 , C07K5/0808
摘要： A compound of general formula (I); A is O, S, CH, NH or NR′, when O links with Z3, Z1 is N or CRZ1, Z2 is CRZ2, when Z1 links with O, Z2 is CH, Z3 is C—Ar; Ra, Rb, Rc and Rd independently is H, OH, halogen or —Y1—Rm; A1 is NH or CH2; R1′ is alkyl, aryl, cycloalkyl, heterocycloalkyl or heteroaryl; A2 is N, O or linking bond; R1 is hydrogen, or, R1 linking covalently with R3 forms C5-C9 saturated or unsaturated hydrocarbon chain substituted by O or N; R3 is alkyl, cycloalkyl, heterocycloalkyl, alkyl substituted by cycloalkyl etc; R4 is alkoxy-CO, alkyl-NHCO, (alkyl)2NCO, or formyl substituted by aryl, cycloalkyl, heterocycloalkyl.
摘要翻译：通式（I）的化合物; A是O，S，CH，NH或NR'，当O与Z3连接时，Z1为N或CRZ1，Z2为CRZ2，当Z1与O连接时，Z2为CH，Z3为C-Ar; Ra，Rb，Rc和Rd独立地是H，OH，卤素或-Y1-Rm; A1是NH或CH2; R 1'是烷基，芳基，环烷基，杂环烷基或杂芳基; A2是N，O或连接键; R1是氢，或者与R3共价连接的R1形成被O或N取代的C5-C9饱和或不饱和烃链; R3是烷基，环烷基，杂环烷基，被环烷基取代的烷基等; R4是烷氧基-CO，烷基-NHCO，（烷基）2NCO或被芳基，环烷基，杂环烷基取代的甲酰基。

2. 发明授权

US08106209B2 Substituted aminothiazole prodrugs of compounds with anti-HCV activity 失效
标题翻译：具有抗HCV活性的化合物的取代的氨基噻唑前药
公开(公告)号：US08106209B2
公开(公告)日：2012-01-31
申请号：US12479213
申请日：2009-06-05
申请人： Cuixan Liu , Avinash Phadke , Xiangzhu Wang , Suoming Zhang
发明人： Cuixan Liu , Avinash Phadke , Xiangzhu Wang , Suoming Zhang
IPC分类号： C07D417/04 , A61K31/44
CPC分类号： C07D417/04 , C07D417/14
摘要： The invention provides amino-substituted aminothiazole compounds of Formula I and Formula II where A is a group of the formula: and the variables X, Y, R, and R1 to R7 are described herein. These compounds are prodrugs of compounds useful as inhibitors of viral replication. Compositions containing such compounds, and methods of treating viral infections with these compounds, as well as to processes and intermediates useful for preparing such compounds are also provided by the invention.
摘要翻译：本发明提供式I和式II的氨基取代的氨基噻唑化合物，其中A是下式的基团：变量X，Y，R 1和R 1至R 7在本文中描述。这些化合物是可用作病毒复制抑制剂的化合物的前药。含有这些化合物的组合物，以及用这些化合物治疗病毒感染的方法，以及可用于制备这些化合物的方法和中间体也由本发明提供。

3. 发明授权

US07906619B2 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication 有权
标题翻译： 4-氨基-4-氧代丁酰基肽作为病毒复制的抑制剂
公开(公告)号：US07906619B2
公开(公告)日：2011-03-15
申请号：US11777745
申请日：2007-07-13
申请人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
发明人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
IPC分类号： A61K38/06
CPC分类号： A61K38/05 , A61K38/00 , A61K38/12 , A61K45/06 , C07K5/02 , C07K5/06078 , C07K5/06139 , C07K5/06165 , C07K5/06191 , C07K5/0808 , C07K5/12
摘要： The invention provides 4-amino-4-oxobutanoyl peptide compounds of Formula I and the pharmaceutically salts and hydrates thereof. The variables R1-R9, R16, R18, R19, n, M, n, M, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. Certain 4-amino-4-oxobutanoyl peptide compounds disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptide compounds and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain 4-amino-4-oxobutanoyl peptide compound as the only active agent or may contain a combination of 4-amino-4-oxobutanoyl peptide containing peptides compound and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections, in mammals.
摘要翻译：本发明提供了式I的4-氨基-4-氧代丁酰基肽化合物及其药学上可接受的盐和水合物。变量R1-R9，R16，R18，R19，n，M，n，M和Z在本文中定义。某些式I化合物可用作抗病毒剂。本文公开的某些4-氨基-4-氧代丁酰基肽化合物是病毒复制的有效和/或选择性抑制剂，特别是丙型肝炎病毒复制。本发明还提供含有一种或多种4-氨基-4-氧代丁酰基肽化合物和一种或多种药学上可接受的载体的药物组合物。这样的药物组合物可以含有4-氨基-4-氧代丁酰基肽化合物作为唯一的活性剂，或者可以含有含有4-氨基-4-氧代丁酰基肽的肽化合物和一种或多种其它药物活性剂的组合。本发明还提供了用于治疗哺乳动物中的病毒感染（包括丙型肝炎感染）的方法。

4. 发明申请

US20100124545A1 CYCLIC CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF AS OF HEPATITIS C VIRUS 失效
标题翻译：周期性羧酰胺化合物及其与乙型肝炎病毒的模拟物
公开(公告)号：US20100124545A1
公开(公告)日：2010-05-20
申请号：US12622753
申请日：2009-11-20
申请人： Suoming Zhang , Avinash Phadke , Milind Deshpande , Venkat Gadhachanda
发明人： Suoming Zhang , Avinash Phadke , Milind Deshpande , Venkat Gadhachanda
IPC分类号： A61K38/21 , A61K38/12 , A61K31/7056 , A61K31/47 , C07K5/12 , C07D215/233 , A61P31/12
CPC分类号： C07K5/0808 , C07K5/0819
摘要： The invention provides cyclic carboxamide compounds and analogues thereof of Formula I and the pharmaceutically salts and hydrates thereof.The variables R, R1, R6-R8, R16, R18, R19, M, n, T, Y, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. Certain cyclic carboxamide compounds and cyclic carboxamide analogues disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more cyclic carboxamide compounds or cyclic carboxamide analogues and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a cyclic carboxamide compound or cyclic carboxamide analogue as the only active agent or may contain a combination of a cyclic carboxamide compound or cyclic carboxamide analogue and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections.
摘要翻译：本发明提供式I的环状羧酰胺化合物及其类似物及其药学上可接受的盐和水合物。变量R，R1，R6-R8，R16，R18，R19，M，n，T，Y和Z在本文中定义。某些式I化合物可用作抗病毒剂。本文公开的某些环状羧酰胺化合物和环状羧酰胺类似物是有效和/或选择性的病毒复制抑制剂，特别是丙型肝炎病毒复制。本发明还提供含有一种或多种环状羧酰胺化合物或环状甲酰胺类似物和一种或多种药学上可接受的载体的药物组合物。这样的药物组合物可以含有环状羧酰胺化合物或环状羧酰胺类似物作为唯一的活性剂，或者可以含有环状羧酰胺化合物或环状甲酰胺类似物和一种或多种其它药学活性剂的组合。本发明还提供了治疗病毒感染的方法，包括丙型肝炎感染。

5. 发明申请

US20090048297A1 4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION 有权
标题翻译：作为病毒复制抑制剂的4-氨基-4-氧代哌啶
公开(公告)号：US20090048297A1
公开(公告)日：2009-02-19
申请号：US11777745
申请日：2007-07-13
申请人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
发明人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
IPC分类号： A61K31/4709 , C07D401/12
CPC分类号： A61K38/05 , A61K38/00 , A61K38/12 , A61K45/06 , C07K5/02 , C07K5/06078 , C07K5/06139 , C07K5/06165 , C07K5/06191 , C07K5/0808 , C07K5/12
摘要： The invention provides 4-amino-4-oxobutanoyl peptide compounds of Formula I and the pharmaceutically salts and hydrates thereof.The variables R1-R9, R16, R18, R19, n, M, n, M, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. Certain 4-amino-4-oxobutanoyl peptide compounds disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptide compounds and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain 4-amino-4-oxobutanoyl peptide compound as the only active agent or may contain a combination of 4-amino-4-oxobutanoyl peptide containing peptides compound and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections, in mammals.
摘要翻译：本发明提供了式I的4-氨基-4-氧代丁酰基肽化合物及其药学上可接受的盐和水合物。变量R1-R9，R16，R18，R19，n，M，n，M和Z在本文中定义。某些式I化合物可用作抗病毒剂。本文公开的某些4-氨基-4-氧代丁酰基肽化合物是病毒复制的有效和/或选择性抑制剂，特别是丙型肝炎病毒复制。本发明还提供含有一种或多种4-氨基-4-氧代丁酰基肽化合物和一种或多种药学上可接受的载体的药物组合物。这样的药物组合物可以含有4-氨基-4-氧代丁酰基肽化合物作为唯一的活性剂，或者可以含有含有4-氨基-4-氧代丁酰基肽的肽化合物和一种或多种其它药物活性剂的组合。本发明还提供了用于治疗哺乳动物中的病毒感染（包括丙型肝炎感染）的方法。

6. 发明申请

US20070212297A1 Amino methyl imidazoles and related compounds as C5a receptor modulators 失效
标题翻译：氨基甲基咪唑和相关化合物作为C5a受体调节剂
公开(公告)号：US20070212297A1
公开(公告)日：2007-09-13
申请号：US11615054
申请日：2006-12-22
申请人： Andrew Thurkauf , He Zhao , Suoming Zhang , Yang Gao
发明人： Andrew Thurkauf , He Zhao , Suoming Zhang , Yang Gao
IPC分类号： A61K51/00
CPC分类号： C07D401/12 , C07D403/12 , C07D405/12 , C07D405/14
摘要： Amino methyl imidazoles of Formula I are provided: wherein R, R1, R2, R3, R4, R5, and R6 are defined herein. Such compounds are ligands of C5a receptors. Preferred compounds of Formula I bind to C5a receptors with high affinity and exhibit neutral antagonist or inverse agonist activity at C5a receptors. This invention also relates to pharmaceutical compositions comprising such compounds. It further relates to the use of such compounds in treating a variety of inflammatory, cardiovascular, and immune system disorders. Additionally, this invention provides labeled amino methyl imidazoles compounds, which are useful as probes for the localization of C5a receptors.
摘要翻译：提供式I的氨基甲基咪唑：其中R 1，R 2，R 2，R 3，R 4， >，R 5和R 6在本文中定义。这些化合物是C5a受体的配体。优选的式I化合物以高亲和力结合C5a受体，并在C5a受体上呈现中性拮抗剂或反向激动剂活性。本发明还涉及包含这些化合物的药物组合物。它还涉及这些化合物在治疗各种炎性，心血管和免疫系统疾病中的用途。此外，本发明提供标记的氨基甲基咪唑化合物，其可用作C5a受体定位的探针。

7. 发明授权

US08614180B2 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication 有权
公开(公告)号：US08614180B2
公开(公告)日：2013-12-24
申请号：US12635270
申请日：2009-12-10
申请人： Avinash Phadke , Dawei Chen , Venkat Gadhachanda , Akihiro Hashimoto , Godwin Pais , Xiangzhu Wang , Atul Agarwal , Ha Young Kim , Shouming Li , Cuixian Liu , Suoming Zhang , Milind Deshpande
发明人： Avinash Phadke , Dawei Chen , Venkat Gadhachanda , Akihiro Hashimoto , Godwin Pais , Xiangzhu Wang , Atul Agarwal , Ha Young Kim , Shouming Li , Cuixian Liu , Suoming Zhang , Milind Deshpande
IPC分类号： A01N37/18
CPC分类号： C07D207/16 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/12 , C07D417/14 , C07D471/08 , C07D487/08 , C07D487/18 , C07D491/113
摘要： The invention provides 4-amino-4-oxobutanoyl peptides of Formula I and the pharmaceutically salts and hydrates thereof. The variables R, R1, R6-R8, R16, R18, R19, M, n, T, Y, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. The 4-amino-4-oxobutanoyl peptides disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptides and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain a 4-amino-4-oxobutanoyl peptides as the only active agent or may contain a combination of a 4-amino-4-oxobutanoyl peptides and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections.

8. 发明申请

US20120108576A1 THIAZOLE COMPOUNDS AND METHODS OF USE 审中-公开
标题翻译：噻唑化合物及其使用方法
公开(公告)号：US20120108576A1
公开(公告)日：2012-05-03
申请号：US13307761
申请日：2011-11-30
申请人： Suoming Zhang , Avinash Phadke , Cuixian Liu , Xiangzhu Wang , Jesse Quinn , Dawei Chen , Venkat Gadhachanda , Shouming Li , Milind Deshpande
发明人： Suoming Zhang , Avinash Phadke , Cuixian Liu , Xiangzhu Wang , Jesse Quinn , Dawei Chen , Venkat Gadhachanda , Shouming Li , Milind Deshpande
IPC分类号： A61K31/541 , A61K31/5377 , A61K31/498 , A61K31/501 , A61K31/496 , A61K31/497 , A61K31/519 , A61K31/506 , A61K31/437 , A61K31/4375 , A61K31/4545 , A61K31/444 , A61K31/4439 , A61K31/433 , A61K31/429 , A61K31/426 , A61K31/427 , C07D239/02 , C07D513/14 , C07D471/04 , C07D417/04 , C07D513/04 , C07D417/14 , C07D277/38 , A61K31/538
CPC分类号： C07D487/04 , C07D277/38 , C07D277/42 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D513/04
摘要： The present invention provides compounds, salts and hydrates of Formula I, wherein the variables Ar1, R2, R3, R4, r, q, and t are defined herein. Certain compounds of Formula I described herein possess potent antiviral activity. The invention also provides compounds of Formula I that are potent and/or selective inhibitors of Hepatitis C virus replication. Certain compounds described herein inhibit assembly of the HCV replication complex. The invention also provides pharmaceutical compositions containing one or more compounds of Formula I, or a salt, solvate, or acylated prodrug of such compounds, and one or more pharmaceutically acceptable carriers, excipients, or diluents. The invention further comprises methods of treating patients suffering from certain infectious diseases by administering to such patients an amount of a compound of Formula I effective to reduce signs or symptoms of the disease. These infectious diseases include viral infections, particularly HCV infections. The invention is particularly includes methods of treating human patients suffering from an infectious disease, but also encompasses methods of treating other animals, including livestock and domesticated companion animals, suffering from an infectious disease. Methods of treatment include administering a compound of Formula I as a single active agent or administering a compound of Formula I in combination with on or more other therapeutic agent.
摘要翻译：本发明提供式I的化合物，盐和水合物，其中变量Ar1，R2，R3，R4，r，q和t在本文中定义。某些本文所述的式I化合物具有有效的抗病毒活性。本发明还提供了作为丙型肝炎病毒复制的有效和/或选择性抑制剂的式I化合物。本文所述的某些化合物抑制HCV复制复合物的组装。本发明还提供含有一种或多种式I化合物或这些化合物的盐，溶剂化物或酰化前药以及一种或多种药学上可接受的载体，赋形剂或稀释剂的药物组合物。本发明还包括通过向这些患者施用一定量的有效降低疾病体征或症状的式I化合物来治疗患有某些感染性疾病的患者的方法。这些传染病包括病毒感染，特别是HCV感染。本发明特别包括治疗患有感染性疾病的人类患者的方法，还包括治疗其它动物（包括患有传染病的家畜和驯养的伴侣动物）的方法。治疗方法包括给予式I化合物作为单一活性剂或将一种式I化合物与一种或多种其它治疗剂组合施用。

9. 发明申请

US20110172187A1 BORON-CONTAINING SMALL MOLECULES 有权
公开(公告)号：US20110172187A1
公开(公告)日：2011-07-14
申请号：US12944690
申请日：2010-11-11
申请人： Vincent S. HERNANDEZ , Xiangeng Li , Suoming ZHANG , Tsutomu AKAMA , Yanchen ZHANG , Yang LIU , Jacob J. PLATTNER , Michael Richard Kevin ALLEY , Yasheen ZHOU , James A. NIEMAN
发明人： Vincent S. HERNANDEZ , Xiangeng Li , Suoming ZHANG , Tsutomu AKAMA , Yanchen ZHANG , Yang LIU , Jacob J. PLATTNER , Michael Richard Kevin ALLEY , Yasheen ZHOU , James A. NIEMAN
IPC分类号： A61K31/69 , C07F5/04 , A61P31/04
CPC分类号： C07F5/025
摘要： This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.

10. 发明申请

US20110070168A1 MACROCYCLIC PEPTIDES AS INHIBITORS OF VIRAL REPLICATION 有权
标题翻译：作为病毒复制的抑制剂的大环肽
公开(公告)号：US20110070168A1
公开(公告)日：2011-03-24
申请号：US12955413
申请日：2010-11-29
申请人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
发明人： Avinash Phadke , Xiangzhu Wang , Suoming Zhang , Atul Agarwal
IPC分类号： A61K38/21 , C07K5/08 , A61K38/06 , C07K5/12 , A61K38/12 , C07K5/10 , A61P31/12 , A61K9/12
CPC分类号： A61K38/05 , A61K38/00 , A61K38/12 , A61K45/06 , C07K5/02 , C07K5/06078 , C07K5/06139 , C07K5/06165 , C07K5/06191 , C07K5/0808 , C07K5/12
摘要： The invention provides 4-amino-4-oxobutanoyl peptide compounds of Formula I and the pharmaceutically salts and hydrates thereof.The variables R1-R9, R16, R18, R19, n, M, n, M, and Z are defined herein. Certain compounds of Formula I are useful as antiviral agents. Certain 4-amino-4-oxobutanoyl peptide compounds disclosed herein are potent and/or selective inhibitors of viral replication, particularly Hepatitis C virus replication. The invention also provides pharmaceutical compositions containing one or more 4-amino-4-oxobutanoyl peptide compounds and one or more pharmaceutically acceptable carriers. Such pharmaceutical compositions may contain 4-amino-4-oxobutanoyl peptide compound as the only active agent or may contain a combination of 4-amino-4-oxobutanoyl peptide containing peptides compound and one or more other pharmaceutically active agents. The invention also provides methods for treating viral infections, including Hepatitis C infections, in mammals.
摘要翻译：本发明提供了式I的4-氨基-4-氧代丁酰基肽化合物及其药学上可接受的盐和水合物。变量R1-R9，R16，R18，R19，n，M，n，M和Z在本文中定义。某些式I化合物可用作抗病毒剂。本文公开的某些4-氨基-4-氧代丁酰基肽化合物是病毒复制的有效和/或选择性抑制剂，特别是丙型肝炎病毒复制。本发明还提供含有一种或多种4-氨基-4-氧代丁酰基肽化合物和一种或多种药学上可接受的载体的药物组合物。这样的药物组合物可以含有4-氨基-4-氧代丁酰基肽化合物作为唯一的活性剂，或者可以含有含有4-氨基-4-氧代丁酰基肽的肽化合物和一种或多种其它药物活性剂的组合。本发明还提供了用于治疗哺乳动物中的病毒感染（包括丙型肝炎感染）的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式